Review
doi: 10.1038/nrc823.
Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs
Affiliations
- PMID: 12189385
- DOI: 10.1038/nrc823
Item in Clipboard
Review
Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs
Nat Rev Cancer.
2002 Jun.
No abstract available
Similar articles
-
Genetic manipulation of drug sensitivity in haematopoietic cells.Expert Rev Mol Med. 2004 Aug 6;6(18):1-24. doi: 10.1017/S146239940400818X. Expert Rev Mol Med. 2004. PMID: 15387894 Review.
-
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.Oncogene. 2003 Jan 23;22(3):370-80. doi: 10.1038/sj.onc.1206168. Oncogene. 2003. PMID: 12545158
-
American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.Science. 2005 Jun 17;308(5729):1735-6. doi: 10.1126/science.308.5729.1735b. Science. 2005. PMID: 15961648 No abstract available.
-
[Development of gene therapy for hematopoietic stem cell using viral vectors].Yi Chuan Xue Bao. 2003 Apr;30(4):382-8. Yi Chuan Xue Bao. 2003. PMID: 12812066 Review. Chinese.
-
Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.Cancer Gene Ther. 2002 Sep;9(9):737-46. doi: 10.1038/sj.cgt.7700490. Cancer Gene Ther. 2002. PMID: 12189523
Cited by
-
Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI.Virol J. 2006 Mar 15;3:14. doi: 10.1186/1743-422X-3-14. Virol J. 2006. PMID: 16539700 Free PMC article.
-
Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.Blood. 2008 Dec 1;112(12):4466-74. doi: 10.1182/blood-2008-03-146571. Epub 2008 Jun 27. Blood. 2008. PMID: 18587011 Free PMC article.
-
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance.Nat Rev Cancer. 2024 Sep;24(9):614-628. doi: 10.1038/s41568-024-00723-5. Epub 2024 Jul 24. Nat Rev Cancer. 2024. PMID: 39048767 Review.
-
PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma.BMC Complement Med Ther. 2020 Aug 15;20(1):252. doi: 10.1186/s12906-020-03041-z. BMC Complement Med Ther. 2020. PMID: 32799864 Free PMC article.
-
Chemoprotection in brain tumor patients: another success for stem cell gene therapy.Mol Ther. 2012 Aug;20(8):1485-7. doi: 10.1038/mt.2012.139. Mol Ther. 2012. PMID: 22850719 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
